Fidanacogene elaparvovec Alternatives Compared
Fidanacogene elaparvovec | Idelvion | BeneFix |
|
---|
Fidanacogene elaparvovec | Idelvion (coagulation factor ix) | BeneFix (coagulation factor ix) |
|
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Hemophilia B. fidanacogene elaparvovec may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Hemophilia B. Idelvion may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Factor IX Deficiency, Hemophilia B. BeneFix may also be used for purposes not listed in this medication guide. |
Related suggestions Hemophilia B
|
|||||||
More about Fidanacogene elaparvovec | More about Idelvion (coagulation factor ix) | More about BeneFix (coagulation factor ix) | ||||||||
Ratings & Reviews | ||||||||||
Be the first to share your experience with this drug. |
Be the first to share your experience with this drug. |
BeneFix has an average rating of 6.0 out of 10 from a total of 1 ratings on Drugs.com. 0% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||
Drug Class | ||||||||||
Side Effects | ||||||||||
See also: fidanacogene elaparvovec side effects in more detail. |
See also: Idelvion side effects in more detail. |
See also: BeneFix side effects in more detail. |
||||||||
Generic Availability | ||||||||||
N/A |
N/A |
N/A |
||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Idelvion prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Forms Available | ||||||||||
N/A |
|
N/A |
||||||||
Brand Names | ||||||||||
Beqvez | Other coagulation factor ix brands include: Alphanine SD, Alprolix, BeneFix, BeneFIX 250 Int'l Units, Ixinity, Mononine, Rebinyn, Rixubis | Other coagulation factor ix brands include: Alphanine SD, Alprolix, BeneFIX 250 Int'l Units, Idelvion, Ixinity, Mononine, Rebinyn, Rixubis | ||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||
N/A |
86.52 hours |
86.52 hours |
||||||||
CSA Schedule ** View glossary of terms | ||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | ||||||||||
Summary unavailable. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
Drug Interactions | ||||||||||
A total of 288 drugs are known to interact with fidanacogene elaparvovec:
|
A total of 5 drugs are known to interact with Idelvion:
|
A total of 5 drugs are known to interact with BeneFix:
|
||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions | ||||||||||
First Approval Date | ||||||||||
N/A |
N/A |
N/A |
||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||
N/A |
N/A |
N/A |
||||||||
More Information | ||||||||||
Patient resources | ||||||||||
Professional Resources | ||||||||||
Related Treatment Guide | ||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.